PAP
ROIV icon

Persistent Asset Partners’s Roivant Sciences ROIV Stock Holding History

Persistent Asset Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-860
Closed -$11.1K – 891
2026
Q1 		$11.1K Hold
860
– – ﹤0.01% 286
2025
Q4 		$25.8K Buy
860
+169
+24% +$3.33K 0.01% 310
2025
Q3 		$36.3K Buy
+691
New +$8.55K 0.02% 191

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Persistent Asset Partners's ROIV Position: Q2 2026 in Review

Persistent Asset Partners opened a new position in Roivant Sciences (ROIV) in Q2 2026: 11,020 shares worth $390K. The stake represents 0.12% of the portfolio and ranks #140 among its holdings. This is a return to the name: Persistent Asset Partners previously reported a position in ROIV as recently as Q4 2025.

Persistent Asset Partners first reported a position in ROIV in Q3 2025 and has held it in 3 quarters since. The position peaked at $419K in Q3 2025. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Persistent Asset Partners held 11,020 shares of Roivant Sciences worth $390K as of Q2 2026.
  • Roivant Sciences was a new Persistent Asset Partners position in Q2 2026.
  • Roivant Sciences made up 0.12% of Persistent Asset Partners's portfolio in Q2 2026, its #140 holding.
  • Persistent Asset Partners first reported a position in Roivant Sciences in Q3 2025 and has held it in 3 quarters since.
  • Persistent Asset Partners's Roivant Sciences position peaked at $419K in Q3 2025.
  • 499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.